TSS
RNTX

Two Sigma Securities’s Rein Therapeutics RNTX Stock Holding History

Two Sigma Securities’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.2K Buy
31,713
+14,459
+84% +$17.9K ﹤0.01% 1289
2025
Q4 		$20K Buy
+17,254
New +$23.8K ﹤0.01% 1182
2025
Q2 		– Sell
-16,271
Closed -$28.8K – 2222
2025
Q1 		$28.8K Buy
+16,271
New +$34.1K ﹤0.01% 1049
2022
Q3 		– Sell
-3,754
Closed -$20K – 3207
2022
Q2 		$20K Buy
+3,754
New +$34.5K ﹤0.01% 1959
2022
Q1 		– Sell
-1,733
Closed -$20K – 2598
2021
Q4 		$20K Buy
1,733
+590
+52% +$9.12K ﹤0.01% 1406
2021
Q3 		$23K Buy
+1,143
New +$25K ﹤0.01% 1453
2019
Q1 		– Sell
-510
Closed -$9K – 2548
2018
Q4 		$9K Buy
+510
New +$20.5K ﹤0.01% 2026

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Two Sigma Securities's RNTX Position: Q1 2026 in Review

Two Sigma Securities increased its Rein Therapeutics (RNTX) stake by 84% in Q1 2026, buying an estimated $17.9K and bringing the position to 31,713 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Two Sigma Securities first reported a position in RNTX in Q4 2018 and has held it in 7 quarters since. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Two Sigma Securities held 31,713 shares of Rein Therapeutics worth $41.2K as of Q1 2026.
  • Two Sigma Securities bought 14,459 Rein Therapeutics shares in Q1 2026, an estimated $17.9K.
  • Rein Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1289 holding.
  • Two Sigma Securities first reported a position in Rein Therapeutics in Q4 2018 and has held it in 7 quarters since.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.